The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.

Abstract

BACKGROUND New hepatitis C virus (HCV) treatments deliver higher cure rates with fewer contraindications, increasing demand for treatment and healthcare costs. The cost-effectiveness of new treatments is unknown. METHODS We conducted a microsimulation of guideline testing followed by alternative treatment regimens for HCV among the US population aged 20… (More)
DOI: 10.1093/cid/civ220

Topics

3 Figures and Tables

Blog articles referencing this paper

Slides referencing similar topics